About Us
Development Programs
Investors
Contact Us

Incannex Nasdaq Presentation

Share this page

Related news

Incannex is a cannabinoid and psychedelic compound medicine development company undertaking six clinical programs guided by our medical advisory board.

About us
Investors
News
Contact Us

Level 23, Rialto South Tower,
525 Collins Street,
Melbourne VIC 3000
info@incannex.com.au